4.7 Review

Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

The next tier of EGFR resistance mutations in lung cancer

Hannah L. Tumbrink et al.

Summary: EGFR mutations play a major role in druggable targets for lung adenocarcinoma, and optimization of EGFR inhibitors has significantly impacted treatment options. However, the emergence of resistance mutations during drug treatment has driven the need for rapid understanding of individual mutations for developing next-generation inhibitors. The field currently faces a large number of combinations of activating mutations and distinct resistance mutations, alongside the approval of osimertinib as a frontline drug for EGFR-mutant lung cancer.

ONCOGENE (2021)

Article Oncology

Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site

Shuo Chen et al.

Summary: The study identified small molecules, such as arsenic trioxide, as compounds that can rescue the structural mutations in p53, reactivating its tumor suppressive function. Arsenic binding stabilizes the DNA-binding loop-sheet-helix motif and overall beta-sandwich fold, providing a new strategy for cancer therapy targeting p53 mutations.

CANCER CELL (2021)

Article Oncology

Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

Viralkumar Davra et al.

Summary: This study demonstrates that targeting Axl expressed on tumor cells and Mertk in the tumor microenvironment could enhance current immunotherapies. Axl and Mertk have distinct functional activities in breast cancer, affecting host antitumor response.

CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

Multi-organ proteomic landscape of COVID-19 autopsies

Xiu Nie et al.

Summary: This study used proteomic analysis to reveal the molecular mechanisms of multi-organ injuries in COVID-19 patients. The data showed significant upregulation of cathepsin L1 in the lung, instead of ACE2. Systemic hyperinflammation, dysregulation of glucose and fatty acid metabolism were detected in multiple organs.
Article Cell Biology

Phosphorylation of PKCδ by FER tips the balance from EGFR degradation to recycling

Ana Lonic et al.

Summary: This study demonstrates the mechanism by which FER-dependent phosphorylation of PKCδ regulates the recycling and degradation of endosomal EGFR, influencing EGFR signaling and cell proliferation in triple-negative breast cancer cells. The dysregulation of this pathway, characterized by increased Y374-PKCδ phosphorylation correlating with arrested late endosome maturation, may contribute to the pathology of triple-negative breast cancer.

JOURNAL OF CELL BIOLOGY (2021)

Article Oncology

Selective exosome exclusion of miR-375 by glioma cells promotes glioma progression by activating the CTGF-EGFR pathway

Xiangdong Xu et al.

Summary: MiR-375 expression is downregulated in gliomas, and it suppresses glioma proliferation, migration, and invasion by inhibiting the CTGF-EGFR signaling pathway. MiR-375-containing exosomes were found in human blood samples from glioma patients, with levels correlating with disease progression. Exosomal miR-375 secretion impacts the activity of the CTGF-EGFR pathway, and once secreted, exosomal miR-375 is not taken back up by glioma cells.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Oncology

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target

Xiuning Le et al.

Summary: EGFR-mutant non-small cell lung cancer exhibits an immune-inert phenotype, with the CD73/adenosine pathway identified as a potential therapeutic target for treatment enhancement.

JOURNAL OF THORACIC ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis

Wei-Hsin Lin et al.

Summary: The research suggests that BM-MSC plays a crucial role in cancer cell dissemination and metastasis in lung cancer models. BM-MSC-induced signaling triggers early dissemination of cancer stem cells and promotes proliferation at secondary sites. Additionally, intercellular signaling regulates the switch between migration and proliferation.

ONCOGENE (2021)

Article Biochemistry & Molecular Biology

Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB

Manikandan Periyasamy et al.

Summary: Chemotherapeutic drugs can induce A3B expression independently of p53, mainly through the activation of DNA repair and NF-κB pathways. The expression of A3B contributes to chemotherapy resistance and can potentially accelerate cancer mutations.

ONCOGENE (2021)

Article Oncology

Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine

Cristina P. R. Xavier et al.

Summary: Research has shown that large EVs released by macrophages contain proteins CHI3L1 and FN1, whose overexpression can lead to increased resistance of PDAC cells to gemcitabine. Partial reversal of gemcitabine resistance can be achieved by inhibiting CHI3L1 and FN1, providing potential targets for pharmacological intervention in PDAC treatment.

CANCER LETTERS (2021)

Article Multidisciplinary Sciences

Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition

Yael Cohen-Sharir et al.

Summary: The study shows that aneuploid cancer cells are more sensitive to genetic perturbation of SAC components and their long-term proliferation is jeopardized. Furthermore, aneuploid cells exhibit aberrant spindle geometry and dynamics, which result in mitotic defects and less-fit karyotypes over time.

NATURE (2021)

Article Multidisciplinary Sciences

Whole-genome doubling confers unique genetic vulnerabilities on tumour cells

Ryan J. Quinton et al.

Summary: Whole-genome doubling (WGD) in human cancers results in genetically unstable tetraploid cells that depend on specific signaling pathways and require the KIF18A gene for viability. Targeting vulnerabilities unique to WGD(+) cells presents a potential strategy for cancer therapy.

NATURE (2021)

Article Biochemistry & Molecular Biology

Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer

Shiqi Ma et al.

Summary: This study revealed the impact of EREG on EGFR-TKI sensitivity and its mechanisms in NSCLC, suggesting macrophage-produced EREG as a potential novel regulator and biomarker for EGFR-TKI therapy in NSCLC.

ONCOGENE (2021)

Article Cell Biology

Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors

Yue Liu et al.

Summary: A new double-chain chimeric receptor STAR was constructed to mediate strong and sensitive TCR-like signaling upon antigen stimulation, showing better antigen sensitivity and less risk of dysfunction compared to traditional CAR-T cells. In multiple solid tumor models, STAR-T cells outperformed BBzCAR-T cells and showed superior antitumor effects.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway

Wenwen Du et al.

Summary: This study demonstrates for the first time that PD-L1 regulates NSCLC cell proliferation through the Gas6/MerTK signaling pathway, and reveals a molecular mechanism by which PD-L1 translocates into the nucleus to promote Gas6 synthesis and activate the MerTK signaling pathway. These findings provide potential implications for PD-L1 targeted immunotherapy in the clinic.

CELL DEATH AND DIFFERENTIATION (2021)

Article Biochemistry & Molecular Biology

A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors

Ina Nemet et al.

Article Multidisciplinary Sciences

MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis

Jiyoung Kim et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy

Jordi Bertran-Alamillo et al.

NATURE COMMUNICATIONS (2019)

Review Oncology

Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer

Alessandro Leonetti et al.

BRITISH JOURNAL OF CANCER (2019)

Review Biochemistry & Molecular Biology

The Hippo Pathway: Biology and Pathophysiology

Shenghong Ma et al.

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88 (2019)

Article Biochemistry & Molecular Biology

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

Khyati N. Shah et al.

NATURE MEDICINE (2019)

Article Biochemistry & Molecular Biology

NTRK1 is a positive regulator of YAP oncogenic function

Xinyuan Yang et al.

ONCOGENE (2019)

Article Multidisciplinary Sciences

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Hirokazu Taniguchi et al.

NATURE COMMUNICATIONS (2019)

Review Oncology

Tumour heterogeneity and resistance to cancer therapies

Ibiayi Dagogo-Jack et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Oncology

β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer

Bernhard W. Renz et al.

CANCER CELL (2018)

Review Oncology

Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives

Chiara Tomasello et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)

Article Multidisciplinary Sciences

Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells

Debangshu Samanta et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Biochemistry & Molecular Biology

Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4

Francesca Zanconato et al.

NATURE MEDICINE (2018)

Article Oncology

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

Imane Chaib et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Article Multidisciplinary Sciences

Hippo pathway mediates resistance to cytotoxic drugs

Taranjit S. Gujral et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Cell Biology

Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers

Monique B. Nilsson et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Multidisciplinary Sciences

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer

Kirstine Jacobsen et al.

NATURE COMMUNICATIONS (2017)

Article Oncology

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

Imane Chaib et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Review Oncology

Understanding and targeting resistance mechanisms in NSCLC

Julia Rotow et al.

NATURE REVIEWS CANCER (2017)

Article Multidisciplinary Sciences

A gp130-Src-YAP module links inflammation to epithelial regeneration

Koji Taniguchi et al.

NATURE (2015)

Article Biochemistry & Molecular Biology

The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking

Leila Belle et al.

SCIENCE SIGNALING (2015)

Article Biochemistry & Molecular Biology

The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking

Leila Belle et al.

SCIENCE SIGNALING (2015)

Article Multidisciplinary Sciences

Genetic modifiers of EGFR dependence in non-small cell lung cancer

Tanaz Sharifnia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Editorial Material Medicine, General & Internal

Mediating Resistance in Oncogene-Driven Cancers

Rafael Rosell

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Biochemistry & Molecular Biology

HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors

S. Gusenbauer et al.

ONCOGENE (2013)

Article Cell Biology

Connective tissue growth factor is a new ligand of epidermal growth factor receptor

Sandra Rayego-Mateos et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2013)

Article Genetics & Heredity

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

Zhenfeng Zhang et al.

NATURE GENETICS (2012)

Article Biochemistry & Molecular Biology

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

Dahu Chen et al.

NATURE MEDICINE (2012)

Article Multidisciplinary Sciences

FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR

Trever G. Bivona et al.

NATURE (2011)

Article Cell Biology

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

Lecia V. Sequist et al.

SCIENCE TRANSLATIONAL MEDICINE (2011)

Article Medicine, Research & Experimental

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

Sizhi Paul Gao et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)